Page last updated: 2024-08-22

fructosamine and mosapride

fructosamine has been researched along with mosapride in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakawa, A; Inui, A; Kasuga, M; Komatsu, Y; Kotani, K; Nishimura, R; Takao, F; Ueno, N1

Trials

1 trial(s) available for fructosamine and mosapride

ArticleYear
Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus.
    Diabetologia, 2002, Volume: 45, Issue:6

    Topics: Base Sequence; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Female; Fructosamine; Gastrointestinal Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Morpholines; Placebos; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Receptor Agonists

2002